ACLARION, INC. Cash and Restricted Cash
ACLARION, INC. (ACON) had Cash and Restricted Cash of $16.31 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $16.31M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $19.03M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $12.04M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.37M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $16.31M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $19.03M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $12.04M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $11.37M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $12.85M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $14.76M 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $463.66K 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $1.32M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $1.18M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $2.14M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $1.03M 10-K · filed 2026-03-18 | |
| 2023-09-30 | $171.45K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $614.52K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $457.98K 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $1.48M 10-K · filed 2025-04-09 | |
| 2022-09-30 | $2.67M 10-Q · filed 2023-11-14 | $2.67M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $3.80M 10-Q · filed 2023-08-25 | |
| 2022-03-31 | $60.45K 10-Q · filed 2023-07-03 | |
| 2021-12-31 | $452.53K 10-K · filed 2024-03-28 | |
| 2021-09-30 | $1.30M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $14.98K 10-K/A · filed 2023-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |